Skip to content

Delta GREENS Food is Medicine Intervention

Delta GREENS Mississippi Food is Medicine Intervention

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06358859
Enrollment
300
Registered
2024-04-11
Start date
2024-06-05
Completion date
2027-05-01
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiometabolic Risk Factors, Diabetes, High Blood Pressure, Nutrition Security, Obesity

Keywords

Food is Medicine, Diabetes, High blood pressure, Cardiometabolic risk factors, Nutrition-related diseases

Brief summary

Mississippi is a place deeply rooted in cultural values, yet also a place where generations of communities have experienced persistent health challenges intertwined with poverty. This project focuses on Bolivar, Washington, and Sunflower, contiguous counties in the Delta that are designated as health disparity populations. Over 65% of the 100,000 residents are Black/African American and \ 30% live at or below the poverty level. Obesity rates are high and the rate of diabetes is almost double the national average. Tufts University received a grant from the National Institute of Minority Health and Health Disparities to develop, test, and evaluate a Food is Medicine program in Mississippi. The Delta GREENS Food is Medicine (FIM) Project, is a collaborative project in Bolivar, Washington, and Sunflower counties in Mississippi. The intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group. The control group will receive produce boxes later, after they complete study activities. The project's primary goal is to improve health outcomes by creating a FIM intervention. The Delta GREENS FIM Project aims to become a model for promoting nutrition security and management of chronic conditions in varied communities nationwide.

Detailed description

Mississippi is a place deeply rooted in cultural values, yet also a place where generations of communities have experienced persistent health challenges intertwined with poverty. In fact, about 77% of Mississippi counties meet the U.S. Department of Agriculture's definition of food deserts. This project focuses on Bolivar, Washington, and Sunflower, contiguous counties in the Delta that are designated as health disparity populations. Over 65% of the 100,000 residents are Black/African American and \ 30% live at or below the poverty level. Obesity rates are high and the rate of diabetes is almost double the national average. Food is medicine programs -- health clinic mobile markets, produce prescription programs, and produce delivery - hold significant promise for addressing the alarming crisis of nutrition-related diseases. Across the U.S., Food is Medicine programs are in their infancy and accelerating at a rapid pace; since 2019, USDA has funded 116 produce prescription grants. However, no studies have evaluated the impact of food is medicine programs in a rigorous, randomized controlled trial measuring objective cardiometabolic risk factors among minority populations in communities with persistent disadvantage. Tufts University received a grant from the National Institute of Minority Health and Health Disparities to develop, test, and evaluate a Food is Medicine program in Mississippi. This study is focused on Delta GREENS Food is Medicine (FIM) Project. Delta GREENS Food is Medicine is a collaborative project in Bolivar, Washington, and Sunflower counties in Mississippi. The intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group. The control group will receive produce boxes later, after they complete study activities. Participants will be patients at Delta Health Center (DHC) clinics in Mississippi. The project capitalizes on the past success of community-based efforts and decades of community-engaged research at Tufts University, including prior nutrition work in the Delta region. Despite its unique cultural and agricultural background, the Mississippi Delta has experienced persistent health challenges intertwined with poverty. By collaborating and building upon previous successes, the Delta GREENS FIM Project aims to address these challenges, and become a model for promoting nutrition security and management of chronic conditions in varied communities nationwide.

Interventions

Regularly distributed fruit and vegetable produce boxes and nutrition education materials.

Sponsors

Tufts University
Lead SponsorOTHER
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
Tougaloo College, Mississippi
CollaboratorUNKNOWN
Delta Health Center, Mississippi
CollaboratorUNKNOWN
Reuben V. Anderson Center
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

The primary objective is to test whether a multi-level, community-engaged intervention with a food-is-medicine program in the Mississippi Delta can improve metabolic disease in specific minority groups. The basic study design is a cluster randomized controlled trial (RCT), with equal numbers of participants randomized to intervention and control groups. Each participant will be enrolled in the study for 12 months. The intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group during their 12-month study period. The control group will receive produce boxes later, after their 12-month study participation has ended. Participants will be patients at participating Delta Health Center (DHC) clinics in Mississippi.

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patient at participating Delta Health Center (DHC) clinics * BMI: ≥ 25 * Hemoglobin A1C (HbA1c): \>5.7 to 8.5%, inclusive

Exclusion criteria

* Type 1 diabetes * Current use of incretin agonists (e.g., semaglutide, dulaglutide, liraglutide) * Uncontrolled hypertension: * Systolic blood pressure \> 160 mmHg * Diastolic blood pressure \> 100 mmHg * Severe symptomatic cardiovascular disease * Recent (6 months) history of: * Myocardial infarction * Percutaneous coronary intervention * Coronary artery bypass graft * Cerebrovascular disease * Participant in diabetes, nutrition, or weight intervention research in the last 12 months * Another family member or household member is a study participant * History of bariatric surgery or considering bariatric surgery in the next year or prior bariatric surgery * Lack of safe, stable residence and ability to store produce * Lack of telephone * Pregnancy/breastfeeding or intended pregnancy in the next year * Drug or alcohol misuse that would impair the ability to complete study activities * Known psychosis or major psychiatric illness that prevents participation in study activities * Any other reason that in the investigators' best judgment places the participants at risk or increases likelihood of poor adherence

Design outcomes

Primary

MeasureTime frameDescription
Change in hemoglobin A1c (HbA1c)12 month study period for each participantChange in HbA1c in the intervention group compared to the control group

Secondary

MeasureTime frameDescription
Change in cardiometabolic risk factor composite score12 month study period for each participantChange in cardiometabolic risk factor composite score which is computed using LDL and non-HDL cholesterol, blood pressure and HbA1c measures), in the intervention group compared to the control group.
Change in BMI12 month study period for each participantChange in body mass index (BMI) in intervention group compared to control group
Change in LDL cholesterol12 month study period for each participantChange in LDL cholesterol levels in intervention group compared to the control group
Change in non-HDL cholesterol12 month study period for each participantChange in non-HDL cholesterol levels in intervention group compared to the control group
Change in blood pressure12 month study period for each participantChange in blood pressure in intervention group compared to the control group
Change in nutrition security, assessed via a survey12 month study period for each participantChange in nutrition security in intervention group compared to the control group. This outcome measure will be assessed via a survey.
Change in dietary intake of fruits and vegetables, assessed via a survey12 month study period for each participantChange in dietary intake of fruits and vegetables in intervention group compared to the control group. This outcome measure will be assessed via a survey.
Change in health care utilization, assessed via review of Electronic Health Records (EHR)12 month study period for each participantChange in health care utilization, including instances of hospitalization and emergency room visit, in intervention group compared to the control group. This outcome measure will be assessed via review of Electronic Health Records (EHR).
Change in food insecurity, assessed via a survey12 month study period for each participantChange in food insecurity in the intervention group compared to the control group. This outcome measure will be assessed via a survey.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORChristina D Economos, PhD

Tufts University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 19, 2026